Table 2.
Rates of Two-Year (1998–2000) Functional Decline by Gender and Age Among 1998 HRS Arthritis Cohort with None-Moderate Baseline Functional Limitation
| Two-Year Functional Decline | ||
|---|---|---|
| Characteristic | % | 95% CI |
| Male (n=1766) | 11.03 | 9.55, 12.51 |
| 65–74 | 6.96 | 5.42, 8.50 |
| 75–84 | 14.66 | 12.03, 17.28 |
| >=85 | 25.18 | 17.14, 33.21 |
| Female (n=3156) | 14.99 | 13.38, 16.60 |
| 65–74 | 9.79 | 8.24, 11.34 |
| 75–84 | 17.91 | 15.13, 20.69 |
| >=85 | 32.33 | 26.51, 38.16 |
| White/Other (n=4028) | 12.89 | 11.58, 14.21 |
| 65–74 | 7.84 | 6.76, 8.93 |
| 75–84 | 16.12 | 13.90, 18.34 |
| >=85 | 29.93 | 24.96, 34.91 |
| AA (n=611) | 18.67 | 15.07, 22.27 |
| 65–74 | 13.36 | 9.88, 16.83 |
| 75–84 | 24.68 | 17.03, 32.32 |
| >=85 | 31.89 | 21.35, 42.43 |
| Hispanic (n=283) | 18.04 | 14.13, 21.97 |
| 65–74 | 15.56 | 9.56, 21.57 |
| 75–84 | 19.54 | 11.23, 27.86 |
| >=85 | 34.11 | 14.34, 53.88 |
| Total (n=4922) | 13.60 | 12.36, 14.84 |
| 65–74 | 8.75 | 7.71, 9.80 |
| 75–84 | 16.80 | 14.69, 18.90 |
| >=85 | 30.29 | 25.89, 34.70 |